Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cooper Companies (COO)

Cooper Companies (COO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cooper Companies 6101 Bollinger Canyon Road Suite 500 San Ramon CA 94583 USA

www.coopercos.com Employees: 16,000 P: 925-460-3600

Sector:

Medical

Description:

The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.'CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.

Key Statistics

Overview:

Market Capitalization, $K 15,105,509
Enterprise Value, $K 17,581,608
Shares Outstanding, K 198,809
Annual Sales, $ 3,895 M
Annual Net Income, $ 392,300 K
Last Quarter Sales, $ 1,060 M
Last Quarter Net Income, $ 98,300 K
EBIT, $ 940,500 K
EBITDA, $ 1,316 M
60-Month Beta 1.05
% of Insider Shareholders 1.98%
% of Institutional Shareholders 24.39%
Float, K 194,873
% Float 98.02%
Short Volume Ratio 0.33

Growth:

1-Year Return -26.62%
3-Year Return -0.44%
5-Year Return -9.15%
5-Year Revenue Growth 46.81%
5-Year Earnings Growth 19.42%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 1.10 on 08/27/25
Next Earnings Date 12/04/25 [AMC]
Earnings Per Share ttm 4.02
EPS Growth vs. Prev Qtr 14.58%
EPS Growth vs. Prev Year 14.58%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.030 on 07/26/23
Next Ex-Dividends Date 07/26/23
Dividend Payable Date 08/11/23
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 02/20/24

COO Ratios

Ratio
Price/Earnings ttm 18.87
Price/Earnings forward 17.33
Price/Earnings to Growth 1.86
Return-on-Equity % 9.82%
Return-on-Assets % 6.54%
Profit Margin % 10.07%
Debt/Equity 0.30
Price/Sales 3.77
Price/Cash Flow 13.57
Price/Book 1.81
Book Value/Share 42.01
Interest Coverage 6.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar